Jeffrey C Miller

USPTO Granted Patents = 86 (Patent Applications = 23)

CIPO Patents = 20 (Patent Applications = 17)

EPO Patents = 32 (Patent Applications = 50)

Average Co-Inventor Count = 3.0

ph-index = 15

Forward Citations = 1,444(Granted Patents)

Forward Citations (Not Self Cited) = 1,172(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Francisco, CA (US) (2011 - 2013)
Pleasanton, CA (US) (2014 - 2015)
San Leandro, CA (US) (2011 - 2016)
Richmond, CA (US) (2008 - 2023)
Brisbane, CA (US) (2023 - 2024)

Company Filing History:

49 out of 145

Sangamo Therapeutics, Inc.

patents

37 out of 160

Sangamo Biosciences, Inc.

The University of Texas System

patents

5. 2 out of 15,475

University of California

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Gene Editing

DNA-Binding Proteins

Engineered Nucleases

Genome Engineering

Huntington's Disease

Hemophilia Treatment

Zinc Finger Proteins

Targeted Gene Modification

Artificial Nucleases

Exogenous Sequence Integration

Sickle Cell Mutation Correction

Regulation of Gene Expression

86 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11920169 - Compositions for linking DNA-binding domains and cleavage domains (2024-03-05),

2. 11845965 - Regulation of gene expression using engineered nucleases (2023-12-19),

3. 11834686 - Engineered target specific base editors (2023-12-05),

4. 11827900 - Engineered target specific nucleases (2023-11-28),

5. 11725218 - Artificial nucleases comprising engineered cleavage half-domains (2023-08-15),

6. 11723952 - Methods and compositions for treating Huntington's Disease (2023-08-15),

7. 11661612 - DNA-binding proteins and uses thereof (2023-05-30),

8. 11634463 - Methods and compositions for treating hemophilia (2023-04-25),

9. 11608492 - Compositions for linking DNA-binding domains and cleavage domains (2023-03-21),

10. 11492643 - Methods and compositions for treatment of a genetic condition (2022-11-08),

11. 11401512 - Engineered target specific nucleases (2022-08-02),

12. 11198883 - Methods and compositions for integration of an exogenous sequence within the genome of plants (2021-12-14),

13. 11136599 - Artifical nucleases comprising engineered cleavage half-domains (2021-10-05),

14. 11123443 - Htt repressors and uses thereof (2021-09-21),

15. 10975393 - Engineered target specific nucleases (2021-04-13),

Title: The Innovative Journey of Jeffrey C. Miller

Introduction: Jeffrey C. Miller, a talented inventor based in Richmond, CA (US), has made significant contributions to the field of innovation with his creative ideas and groundbreaking inventions.

Latest Patents: Jeffrey C. Miller holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Jeffrey C. Miller has established himself as a visionary inventor known for his ability to transform ideas into tangible products. He has worked with leading companies to bring innovative concepts to the market successfully.

Collaborations: Throughout his career, Jeffrey C. Miller has collaborated with top researchers, engineers, and designers to push the boundaries of innovation. His partnerships have led to the development of cutting-edge technologies that have revolutionized their respective industries.

Conclusion: Jeffrey C. Miller's passion for innovation, coupled with his relentless drive to create, has solidified his position as a respected inventor in the field. His dedication to pushing the limits of what is possible continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.